- Home
- L vs TEVA Comparison
L vs TEVA Comparison
Compare L & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- L
- TEVA
- Stock Information
- Founded
- L 1969
- TEVA 1901
- Country
- L United States
- TEVA Israel
- Employees
- L N/A
- TEVA N/A
- Industry
- L Property-Casualty Insurers
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- L Finance
- TEVA Health Care
- Exchange
- L Nasdaq
- TEVA Nasdaq
- Market Cap
- L 21.1B
- TEVA 21.2B
- IPO Year
- L N/A
- TEVA N/A
- Fundamental
- Price
- L $100.16
- TEVA $18.96
- Analyst Decision
- L
- TEVA Strong Buy
- Analyst Count
- L 0
- TEVA 7
- Target Price
- L N/A
- TEVA $25.57
- AVG Volume (30 Days)
- L 693.9K
- TEVA 9.0M
- Earning Date
- L 11-03-2025
- TEVA 11-05-2025
- Dividend Yield
- L 0.25%
- TEVA N/A
- EPS Growth
- L N/A
- TEVA N/A
- EPS
- L 6.28
- TEVA N/A
- Revenue
- L $18,061,000,000.00
- TEVA $16,628,000,000.00
- Revenue This Year
- L N/A
- TEVA $4.37
- Revenue Next Year
- L N/A
- TEVA $0.67
- P/E Ratio
- L $15.93
- TEVA N/A
- Revenue Growth
- L 8.27
- TEVA 2.08
- 52 Week Low
- L $75.16
- TEVA $12.47
- 52 Week High
- L $103.52
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- L 53.01
- TEVA 43.30
- Support Level
- L $97.88
- TEVA $18.83
- Resistance Level
- L $102.73
- TEVA $20.10
- Average True Range (ATR)
- L 1.35
- TEVA 0.45
- MACD
- L -0.36
- TEVA -0.17
- Stochastic Oscillator
- L 40.48
- TEVA 6.90
About L Loews Corporation
Loews Corp is a holding company along with its subsidiary engaged in commercial property and casualty insurance, transportation and storage of natural gas and natural gas liquids, operation of a chain of hotels, and also in the manufacture of rigid plastic packaging solutions. It has four reportable segments comprised of three individual consolidated operating subsidiaries, CNA Financial Corporation, Boardwalk Pipeline Partners, LP and Loews Hotels Holding Corporation; and the Corporate segment.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.